On November 1, the Centers for Medicare & Medicaid Services (“CMS”) surprisingly finalized a proposal to reduce reimbursement by almost 27 percent for separately payable drugs purchased at reduced prices under the 340B drug discount program (“340B Program”). Currently, all 340B-participating hospitals (“Covered Entities”) except for critical access hospitals (“CAHs”) receive Medicare OPPS payments of 6…Read More
Medicare’s 340B Payment Cut: What Does It Mean for All Hospitals?
Posted on November 8, 2017 in Health Law News
Published by: Hall Render